Profile data is unavailable for this security.
About the company
HCA Healthcare, Inc. is a health care services company. The Company owns, manages or operates hospitals, freestanding surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, physician practices, home health, hospice, outpatient physical therapy home and community-based services providers, and various other facilities. It also operates outpatient health care facilities, which include freestanding ambulatory surgery centers (ASCs), freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, comprehensive rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices and other facilities. It operates about 186 hospitals, comprised of 178 general, acute care hospitals, six behavioral hospitals and two rehabilitation hospitals.
- Revenue in USD (TTM)69.62bn
- Net income in USD5.93bn
- Incorporated2010
- Employees220.00k
- LocationHCA Healthcare IncOne Park PlazaNASHVILLE 37203United StatesUSA
- Phone+1 (615) 344-9551
- Fax+1 (302) 655-5049
- Websitehttps://hcahealthcare.com/
Mergers & acquisitions
| Acquired company | HCA:NYQ since announced | Transaction value |
|---|---|---|
| Valesco Holdings LLC | -14.95% | -- |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Quest Diagnostics Inc | 9.54bn | 838.00m | 18.01bn | 40.00k | 21.66 | 2.65 | 13.49 | 1.89 | 7.45 | 7.45 | 84.79 | 60.79 | 0.645 | 34.77 | 7.18 | 238,475.00 | 5.87 | 9.28 | 6.77 | 10.81 | 32.94 | 36.64 | 9.10 | 12.97 | 1.17 | 8.87 | 0.4746 | 25.07 | -6.38 | 4.20 | -9.77 | 3.40 | 1.27 | 7.43 |
| Labcorp Holdings Inc | 12.71bn | 435.50m | 19.89bn | 67.00k | 46.09 | 2.44 | 18.84 | 1.56 | 5.16 | 5.16 | 150.40 | 97.61 | 0.7162 | 19.41 | 5.93 | 189,743.30 | 2.46 | 6.27 | 3.00 | 7.37 | 27.92 | 32.33 | 3.44 | 9.51 | 1.30 | 5.59 | 0.455 | -- | 2.51 | 1.42 | -62.16 | -16.40 | 3.62 | -- |
| Natera Inc | 1.53bn | -214.69m | 20.76bn | 3.28k | -- | 23.72 | -- | 13.55 | -1.77 | -1.77 | 12.59 | 7.08 | 1.01 | 14.29 | 5.45 | 466,774.80 | -14.14 | -36.17 | -17.55 | -46.60 | 57.66 | 45.88 | -14.01 | -56.15 | 4.23 | -- | 0.2947 | -- | 31.99 | 33.26 | 20.63 | -- | 58.81 | -- |
| Centene Corp | 161.73bn | 3.07bn | 29.84bn | 67.70k | 10.25 | 1.10 | 6.95 | 0.1845 | 5.77 | 5.77 | 303.72 | 53.53 | 1.94 | -- | 9.57 | 2,388,863.00 | 3.66 | 2.58 | 6.39 | 3.99 | 10.37 | 11.59 | 1.89 | 1.37 | -- | 4.06 | 0.3911 | 0.00 | 6.54 | 20.70 | 124.79 | 24.59 | 3.43 | -- |
| Humana Inc | 115.01bn | 1.36bn | 35.40bn | 67.60k | 26.03 | 2.02 | 14.72 | 0.3078 | 11.29 | 11.29 | 948.23 | 145.88 | 2.17 | -- | -- | 1,701,331.00 | 2.72 | 7.57 | -- | -- | -- | -- | 1.25 | 3.35 | -- | 5.38 | 0.4249 | 12.54 | 14.54 | 13.33 | -11.30 | 7.65 | 10.41 | 13.25 |
| CVS Health Corp | 368.91bn | 5.02bn | 71.52bn | 300.00k | 14.44 | 0.9539 | 7.45 | 0.1939 | 3.94 | 3.94 | 290.60 | 59.57 | 1.46 | 17.78 | 36.33 | 1,229,707.00 | 1.99 | 3.03 | 2.97 | 4.20 | 14.20 | 17.07 | 1.36 | 2.30 | 0.5872 | 3.88 | 0.466 | 40.46 | 10.95 | 12.95 | 93.55 | -- | 8.27 | 3.89 |
| HCA Healthcare Inc | 69.62bn | 5.93bn | 84.35bn | 220.00k | 14.94 | -- | 8.37 | 1.21 | 22.28 | 22.28 | 261.95 | -8.57 | 1.22 | 5.54 | 7.29 | 316,459.10 | 11.98 | 11.99 | 16.88 | 15.75 | 84.85 | 84.10 | 9.81 | 10.17 | 0.9991 | 5.30 | 0.982 | 10.54 | 7.86 | 6.84 | -7.11 | 10.13 | 5.83 | 11.38 |
| Cigna Group | 232.59bn | 3.04bn | 89.95bn | 72.50k | 30.50 | 2.15 | 14.41 | 0.3868 | 10.60 | 10.60 | 811.50 | 150.61 | 1.51 | 43.48 | 9.91 | 3,208,083.00 | 2.18 | 4.09 | 3.30 | 5.55 | 11.21 | 13.98 | 1.44 | 3.61 | 0.7736 | 2.33 | 0.4368 | 13.69 | 8.17 | 32.15 | -22.97 | 14.42 | 24.40 | 161.81 |
| Elevance Health Inc | 174.02bn | 6.42bn | 92.18bn | 104.90k | 14.49 | 2.11 | 11.81 | 0.5298 | 27.44 | 27.44 | 743.42 | 188.74 | 1.53 | -- | -- | 1,658,866.00 | 5.63 | 6.03 | -- | -- | -- | -- | 3.67 | 3.96 | -- | 8.36 | 0.3822 | 20.18 | 9.42 | 13.21 | 1.58 | 9.97 | 1.42 | 14.56 |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 30 Sep 2024 | 15.17m | 5.88% |
| Sanders Capital LLCas of 30 Sep 2024 | 11.54m | 4.47% |
| BlackRock Fund Advisorsas of 30 Sep 2024 | 8.89m | 3.45% |
| SSgA Funds Management, Inc.as of 30 Sep 2024 | 8.32m | 3.22% |
| Wellington Management Co. LLPas of 30 Sep 2024 | 6.53m | 2.53% |
| First Eagle Investment Management LLCas of 30 Sep 2024 | 4.48m | 1.74% |
| Geode Capital Management LLCas of 30 Sep 2024 | 3.82m | 1.48% |
| Capital Research & Management Co. (World Investors)as of 30 Sep 2024 | 2.91m | 1.13% |
| Norges Bank Investment Managementas of 30 Jun 2024 | 2.87m | 1.11% |
| RBC Global Asset Management (UK) Ltd.as of 30 Sep 2024 | 2.64m | 1.02% |
